Li Tao, Liu Tongjun, Wang Min, Zhang Mingwei
Department of Colorectal and Anal Surgery, The Second Hospital of Jilin University, Changchun, China.
Medicine (Baltimore). 2018 Sep;97(37):e12359. doi: 10.1097/MD.0000000000012359.
Hepatoid gastric adenocarcinoma is a rare type of gastric cancer. The phenomenon of neuroendocrine differentiation (NED) in gastrointestinal tumor needs further research. Both hepatoid adenocarcinoma and neuroendocrine differentiation are the factors leading to a poor prognosis of gastric cancer. However, there is still no specific treatment.
A 60-year-old man who had a pain and distention in his upper abdomen presented melena. Gastroscopy and pathology revealed a gastric cancer.
Postoperative pathology revealed a hepatoid gastric adenocarcinoma. Immunohistochemical analysis showed a-fetoprotein (AFP), hepatocyte, synaptophysin (Syn), and chromogranin A (CgA) positive, and Ki67 60% positive. A-fetoprotein producing hepatoid gastric adenocarcinoma with NED is diagnosed.
The patient was treated with an R2 radical gastrectomy, but refused chemotherapy.
The AFP level was >2000 ng/mL (0-8.78) half a year after the surgery. There was no obvious abnormality from computed tomography (CT). The patient refused positron emission tomography computed tomography (PET-CT) and left the hospital.
Hepatoid adenocarcinoma and neuroendocrine differentiation are the factors leading to a poor prognosis of gastric cancer. It relapses easily. Long-term follow-up and regular examinations are necessary to detect relapses.
肝样型胃腺癌是一种罕见的胃癌类型。胃肠道肿瘤中的神经内分泌分化(NED)现象需要进一步研究。肝样腺癌和神经内分泌分化都是导致胃癌预后不良的因素。然而,目前仍没有特异性治疗方法。
一名60岁男性,上腹部疼痛、胀满,出现黑便。胃镜及病理检查显示为胃癌。
术后病理显示为肝样型胃腺癌。免疫组化分析显示甲胎蛋白(AFP)、肝细胞、突触素(Syn)和嗜铬粒蛋白A(CgA)呈阳性,Ki67阳性率为60%。诊断为伴有NED的产甲胎蛋白肝样型胃腺癌。
患者接受了R2根治性胃切除术,但拒绝化疗。
术后半年,AFP水平>2000 ng/mL(0 - 8.78)。计算机断层扫描(CT)未发现明显异常。患者拒绝正电子发射断层扫描计算机断层扫描(PET - CT)并出院。
肝样腺癌和神经内分泌分化是导致胃癌预后不良的因素。其容易复发。需要长期随访和定期检查以发现复发情况。